USA flag logo/image

An Official Website of the United States Government

Tissue and Airway Evaluation for Emphysema Interventions

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
70929
Program Year/Program:
2004 / SBIR
Agency Tracking Number:
HL075953
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
VIDA DIAGNOSTICS, INC.
VIDA DIAGNOSTICS, INC. 100 OAKDALE CAMPUS, #231 TIC IOWA CITY, IA -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2004
Title: Tissue and Airway Evaluation for Emphysema Interventions
Agency: HHS
Contract: 1R43HL075953-01A1
Award Amount: $100,000.00
 

Abstract:

DESCRIPTION (provided by applicant): The widespread deployment of high-speed multi-detector CT (MDCT) scanners in the US market is creating opportunities for 3D analysis as single breath hold scans with isotropic voxels is routinely performed using these machines. This increase in the quality and quantity of lung scan data will demand routine use of quantitative tools to assess airway structures and parenchymal tissue distal to and subtended by the segmented airways. Integrated quantitative analysis of bronchial structures and lobar-level parenchymal tissue will allow for more accurate diagnosis of focal lung disease to aid existing interventions such as lung volume reduction surgery as well as newer intra-bronchial valve technology that is currently entering human trials. Specific Aims: 1) Develop and demonstrate proof of concept for MDCT image analysis incorporating lung and lobe segmentation, airway tree segmentation, and intensity-based lung pathology assessment for emphysema. This will include: a) 3D methodologies for partitioning the lobes into surgically-accessible and surgically-inaccessible regions b) 3D methodologies for identification of low attenuation clusters (LACs) to assess distribution of "hole" sizes on a lobar basis. c) application of these methods to both standard-dose and low-dose CT data sets. 2) Develop and demonstrate proof of concept for MDCT image analysis incorporating lung and lobe segmentation, airway tree segmentation, and intensity-based lung pathology assessment for the guidance of endobronchial interventions to treat emphysema. Long-term development of this technology in the future will include integration of our patented adaptive multiple feature method of parenchymal tissue analysis to facilitate integrated quantitative analysis of other lung pathologies and the development of longitudinal analysis methods to allow the use of these methods in ongoing characterization of COPD patients and those with emphysema in particular.

Principal Investigator:

John T. Garber
2036824515
JOHNGARBER@VIDADIAGNOSTICS.COM

Business Contact:

Michael Sims
3193391265
MSSIMS@ADELPHIA.NET
Small Business Information at Submission:

VIDA TECHNOLOGIES
TECHNOLOGY INNOVATION CENTER 100 OAKDALE CAMPUS, SUITE 19 TIC IOWA CITY, IA 52242

EIN/Tax ID: 421434927
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No